Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01804-X/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_easd24&_hsenc=p2ANqtz-8j78xJDjg_J_kkOq_nrXA2PutDgKyhHgivkC466rYY40SPx-bqF4GKcZBdaZYgbOGneZDmGO8_kTWy2dN3Fr9tioKAUw&_hsmi=323969171&utm_content=323969171&utm_source=hs_email